Canada Life’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $203K | Buy |
57,844
+16,886
| +41% | +$54K | ﹤0.01% | 1596 |
|
|
2025
Q4 | $112K | Buy |
40,958
+6,933
| +20% | +$16K | ﹤0.01% | 1705 |
|
|
2025
Q3 | $76K | Buy |
34,025
+3,621
| +12% | +$8.55K | ﹤0.01% | 1790 |
|
|
2025
Q2 | $52K | Sell |
30,404
-29,059
| -49% | -$72.3K | ﹤0.01% | 1829 |
|
|
2025
Q1 | $198K | Buy |
59,463
+2,198
| +4% | +$11.3K | ﹤0.01% | 1722 |
|
|
2024
Q4 | $424K | Sell |
57,265
-3,484
| -6% | -$32.3K | ﹤0.01% | 1668 |
|
|
2024
Q3 | $571K | Buy |
60,749
+737
| +1% | +$6.98K | ﹤0.01% | 1648 |
|
|
2024
Q2 | $481K | Buy |
60,012
+16,134
| +37% | +$173K | ﹤0.01% | 1683 |
|
|
2024
Q1 | $650K | Buy |
43,878
+20,778
| +90% | +$242K | ﹤0.01% | 1622 |
|
|
2023
Q4 | $187K | Sell |
23,100
-1,125
| -5% | -$5.89K | ﹤0.01% | 1851 |
|
|
2023
Q3 | $110K | Buy |
24,225
+8,304
| +52% | +$54.2K | ﹤0.01% | 1944 |
|
|
2023
Q2 | $113K | Buy |
15,921
+7,580
| +91% | +$54.3K | ﹤0.01% | 1908 |
|
|
2023
Q1 | $51K | Buy |
8,341
+671
| +9% | +$4.63K | ﹤0.01% | 2062 |
|
|
2022
Q4 | $49K | Buy |
7,670
+335
| +5% | +$2.62K | ﹤0.01% | 2075 |
|
|
2022
Q3 | $70K | Buy |
7,335
+167
| +2% | +$1.93K | ﹤0.01% | 2048 |
|
|
2022
Q2 | $79K | Buy |
7,168
+156
| +2% | +$2.04K | ﹤0.01% | 1958 |
|
|
2022
Q1 | $123K | Buy |
7,012
+161
| +2% | +$2.49K | ﹤0.01% | 1953 |
|
|
2021
Q4 | $130K | Buy |
6,851
+153
| +2% | +$3.37K | ﹤0.01% | 1954 |
|
|
2021
Q3 | $166K | Hold |
6,698
| – | – | ﹤0.01% | 1940 |
|
|
2021
Q2 | $174K | Hold |
6,698
| – | – | ﹤0.01% | 1959 |
|
|
2021
Q1 | $211K | Sell |
6,698
-460
| -6% | -$19.1K | ﹤0.01% | 1938 |
|
|
2020
Q4 | $332K | Hold |
7,158
| – | – | ﹤0.01% | 1848 |
|
|
2020
Q3 | $236K | Hold |
7,158
| – | – | ﹤0.01% | 1860 |
|
|
2020
Q2 | $195K | Hold |
7,158
| – | – | ﹤0.01% | 1908 |
|
|
2020
Q1 | $216K | Hold |
7,158
| – | – | ﹤0.01% | 1795 |
|
|
2019
Q4 | $196K | Buy |
+7,158
| New | +$163K | ﹤0.01% | 1932 |
|
|
2019
Q3 | – | Sell |
-14,538
| Closed | -$355K | – | 1686 |
|
|
2019
Q2 | $355K | Hold |
14,538
| – | – | ﹤0.01% | 1881 |
|
|
2019
Q1 | $138K | Hold |
14,538
| – | – | ﹤0.01% | 1969 |
|
|
2018
Q4 | $124K | Buy |
14,538
+5,853
| +67% | +$56.5K | ﹤0.01% | 2076 |
|
|
2018
Q3 | $97K | Hold |
8,685
| – | – | ﹤0.01% | 2200 |
|
|
2018
Q2 | $111K | Hold |
8,685
| – | – | ﹤0.01% | 2153 |
|
|
2018
Q1 | $147K | Sell |
8,685
-6,856
| -44% | -$104K | ﹤0.01% | 2042 |
|
|
2017
Q4 | $123K | Buy |
+15,541
| New | +$125K | ﹤0.01% | 2114 |
|
Other funds holding IOVA
MFM
VCM
VPM
ICM
Canada Life's IOVA Position: Q1 2026 in Review
Canada Life increased its Iovance Biotherapeutics (IOVA) stake by 41% in Q1 2026, buying an estimated $54K and bringing the position to 57,844 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #1596.
Canada Life first reported a position in IOVA in Q4 2017 and has held it in 33 quarters since. The position peaked at $650K in Q1 2024. 285 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.
- Canada Life held 57,844 shares of Iovance Biotherapeutics worth $203K as of Q1 2026.
- Canada Life bought 16,886 Iovance Biotherapeutics shares in Q1 2026, an estimated $54K.
- Iovance Biotherapeutics made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1596 holding.
- Canada Life first reported a position in Iovance Biotherapeutics in Q4 2017 and has held it in 33 quarters since.
- Canada Life's Iovance Biotherapeutics position peaked at $650K in Q1 2024.
- 285 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.